cangrelor (Kengreal)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

What is cangrelor, and how does it work (mechanism of action)?

  • Cangrelor is an anti-platelet drug, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Cangrelor prevents blood clots by reversibly binding to the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP) from activating platelets. It belongs to a class of drugs called P2Y12 inhibitors. Other drugs in this class include
    • clopidogrel (Plavix),
    • ticagrelor (Brilinta), and
    • prasugrel (Effient).
  • Cangrelor is different from other P2Y12 inhibitors because it prevents clotting faster and its effect does not last as long after it is stopped. After administration, platelet inhibition begins within 2 minutes, lasts for the duration of the infusion, and platelet function returns to normal within 1 hour after stopping the infusion.

What brand names are available for cangrelor?


Is cangrelor available as a generic drug?


Do I need a prescription for cangrelor?


What are the uses for cangrelor?

  • Cangrelor is used during percutaneous coronary intervention (PCI) for reducing the risk of heart attacks, repeat coronary revascularization, and stent thrombosis (ST) in patients who have not been treated with another P2Y12 platelet inhibitor and are not receiving a glycoprotein IIb/IIIa inhibitor, another class of platelet inhibitors.

What are the side effects of cangrelor?

The most common adverse effect of cangrelor are:

Other side effects include:

  • Increased risk of kidney impairment

Possible serious side effects include:

Medically Reviewed by a Doctor on 9/21/2016

Quick GuideHeart Disease: Symptoms, Signs, and Causes

Heart Disease: Symptoms, Signs, and Causes
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Heart Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors